ChanRx
Cleveland, US · Delaware corporation · 2 known investors
Founders & leadership
HD
Howard DittrichExecutive
RB
Robert Baltera, Jr.Executive
RK
Rajesh KhoslaNamed on SEC filing
JG
Jim GrahamNamed on SEC filing
AB
Arthur BrownNamed on SEC filing
Board
KL
Kevin LalandeBoard director
JD
Jerel DavisBoard director
JT
Investors · 2
Reported raises · per SEC filings
Form D private placements$22.1M disclosed across 3 rounds · 2011–2015
▶$4.5MraisedJul 2015 · 8 investors · PharmaceuticalsRule 506(b)
▶$4.5MraisedJul 2015 · 8 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Kevin LalandeDirector
- James TopperDirector
- Robert Baltera, Jr.Executive Officer, Director
- Brian FarmerExecutive Officer
- Jerel DavisDirector
- Howard DittrichExecutive Officer
- Offering amount
- $4.7M
- Amount sold
- $4.5M
- First sale
- Nov 2011
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$16.6MraisedFeb 2015 · 18 investors · PharmaceuticalsRule 506(b)
▶$16.6MraisedFeb 2015 · 18 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Kevin LalandeDirector
- Howard DittrichExecutive Officer
- Robert Baltera, Jr.Executive Officer, Director
- Jerel DavisDirector
- James TopperDirector
- Offering amount
- $31.9M
- Amount sold
- $16.6M
- First sale
- Feb 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1MraisedJun 2014 · 7 investors · PharmaceuticalsRule 506(b)
▶$1MraisedJun 2014 · 7 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Rajesh KhoslaExecutive Officer, Director
- Jim GrahamDirector
- Kevin LalandeDirector
- Arthur BrownExecutive Officer, Director
- Howard DittrichExecutive Officer
- Offering amount
- $1M
- Amount sold
- $1M
- Minimum investment
- $3.5K
- First sale
- May 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are ChanRx's investors?
- ChanRx's investors include Frazier Life Sciences, Sante Health Ventures.
- How much funding has ChanRx raised?
- ChanRx has disclosed $22.1M raised across 3 rounds.
- Where is ChanRx headquartered?
- ChanRx is headquartered in Cleveland, US.